|
|
 |
|
Viewing report
|
|
|
|
Biopharmaceuticals Market Trends & Competition (Japanese Version)
Fuji-Keizai USA, Inc., July 2010, Pages: 172
Today’s pharmaceutical industry is shifting toward biopharmaceuticals at a drastic speed. In 2009, sales of biopharmaceutical drugs accounted for 13% of the total sales of pharmaceuticals. And today, biopharmaceuticals account for 25% of all pharmaceuticals in the development pipeline. We expect that biopharmaceuticals will maintain double digit growth in the years to come, and form a rapidly growing market.
Eying this dramatically expanding market, companies are expanding biopharmaceutical discovery and development, and becoming active in M&A activities including involvement in bio-ventures. As a result, competition is becoming increasingly fierce.
In this study, we describe and report on the current state and future trends of biopharmaceutical drugs in the global market, including:
1. Market Overview
2. Worldwide Biopharmaceutical Drug Market Trends, 2009-2013
3. US Biopharmaceutical Drug Market Trends
- US Sales of Biopharmaceutical Drugs by Disease Category, 2009-2013
- New Drug Market Entries by Disease Category, 2009-2013
- Manufacturers’ Share by Disease Category
4. Worldwide Innovative Biopharmaceutical Dug Development by Disease Category
- New Drug Pipelines by Disease Category
- New Players to Enter the Market by Disease Category
- Beyond the Pipeline: Hot Categories and Players’ Product Development Strategy
5. Worldwide Biopharmaceutical Drug Strategies by Major Company
- Major Alliances, M&A and IP
- Worldwide Biopharmaceutical Drug Strategies by Major Company
- Worldwide Biopharmaceutical Drug R&D by Major Company
- Patents, Business Development & Challenges for Worldwide Biopharmaceutical Drug by Major Company
6. Important Findings and Suggestions for Business Opportunities
Disease Categories:
Alzheimer’s disease, Anemia, Arthritis, Asthma, Cancer, CAPS, Diabetes, Fabry disease, Gaucher’s disease, Growth hormone deficiency, Hepatitis C, HIV, Lupus, Multiple sclerosis, Neutropenia, Osteoporosis, Parkinson’s disease, Transplant rejection, Ulcerative colitis, Vaccines, Other conditions.
This title is also available in the following language
Biopharmaceuticals Market Trends & Competition (English Version)
Customers who bought this item also bought
Biopharmaceuticals Market Trends & Competition
Global Market: Biopharmaceuticals Market Trends & Competition
Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis
Alzheimer Disease - New Drugs, Markets and Companies
Transdermal Drug Delivery - Technologies, Markets, and Companies
Alzheimer's Disease: Competing Treatments and Market Entry Considerations
Licensing Opportunities: Neurology
Alzheimer's Disease: Markets, Pipeline and Opportunities 2009
Drugs for the Diseases of Aging
Alzheimer's Disease: Drug Treatment Strategies - 2010
|
|
|
|
